← Product Code [HBA](/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/HBA) · K112598 # AMERICAN SURGICAL COMPANY/ NEUROSURGICAL SPONGES (BRAND) (K112598) _American Surgical Company, LLC · HBA · Jun 20, 2013 · Neurology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/HBA/K112598 ## Device Facts - **Applicant:** American Surgical Company, LLC - **Product Code:** [HBA](/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/HBA.md) - **Decision Date:** Jun 20, 2013 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 882.4700 - **Device Class:** Class 2 - **Review Panel:** Neurology ## Indications for Use The device is intended to be used by trained physicians during neurosurgical procedures to protect neural tissues from drying, abrasion, or contamination and to absorb fluids. ## Device Story Neurosurgical sponge; non-adherent, strung, x-ray detectable, sterile, disposable. Composed of cotton, polyester, or rayon substrate; one side covered with thin layer of polytetrafluoroethylene (PTFE) (0.001", 0.003", or 0.005" thickness). Used by physicians during neurosurgical procedures. PTFE layer enhances material stiffness and non-adherence while maintaining flexibility. Protects neural tissues from drying, abrasion, or contamination; absorbs fluids. ## Clinical Evidence No clinical data. Bench testing only. Biocompatibility testing (cytotoxicity, sensitization, irritation) performed per ISO-10993 and FDA Blue Book Guidance G95-1. Peel testing conducted to quantify force required to separate substrate and PTFE layers. ## Technological Characteristics Materials: cotton, polyester, or rayon substrate; polytetrafluoroethylene (PTFE) coating. Dimensions: 6mm x 76mm x 76mm. Principle: mechanical protection and fluid absorption. Sterile, disposable. No energy source. No software. ## Regulatory Identification A neurosurgical paddie is a pad used during surgery to protect nervous tissue, absorb fluids, or stop bleeding. ## Predicate Devices - American Surgical Sponges (brand) Neurosurgical Sponges ([K962807](/device/K962807.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ # KI12598 ### 2.0 510(k) Summary # JUN 2 0 2013 510(K) Owner: American Surgical Company, LLC (formerly American Surgical Sponges, LLC and American Silk Sutures Inc) 82 Sanderson Avenue, Suite 212 Lynn, MA 01902 781-592-7200 Owner/Operator Number: 10030544 ## Submitter: Contact: Erik Piasio Managing Director Tel: 781-592-7200 Fax: 781-595-5460 Email: Erik.Piasio@americansurgical.com Email: lkahler@rcinsightgroup.com Manufacturer: American Surgical Company, LLC 82 Sanderson Avenue, Suite 212 Lynn, MA 01902 781-592-7200 Registration Number: 1221144 Date Prepared: 01 September 2011 Trade name: American Surgical Sponges (brand) Neurosurgical Sponges Lori Kahler The RC Insight Group 461 Main Street, Suite 217 Pawtucket, RI 02860 Tel/Fax: 401-722-1811 Common name: Neurosurgical Paddie or Sponge Classification name: 21 CFR § 882.4700 Product Code(s): HBA (neurosurgical paddie) Classification: Class II Current Legally Marketed Device: American Surgical Company Special 510(k) {1}------------------------------------------------ American Surgical Sponges (brand) Neurosurgical Sponges K962807 ### Summary Description of the Device: The device is a non-adherent, strung, x-ray detectable surgical sponge that is sterile and disposable. The American Surgical Sponges (brand) product line is made from cotton, polyester, or rayon in various sizes and shapes and has been first marketed since 1985. The current cleared product line includes the Telfa® Sponges, which are cotton surgical sponges covered on both sides with polyethylene terephthalate. The Telfa® Sponges provide additional stiffness to the neurosurgical sponges. The new proposed addition to the product line includes neurosurgical sponges (cotton, polyester, or rayon) covered on one side with a thin single layer of polytetrafluoroethylene (PTFE) to enhance the material stiffness and non-adherence properties while maintaining flexibility of the sponge. The polytetrafluoroethylene (PTFE) layer will be provided in a choice of three thicknesses, 0.001", 0.003" or 0.005". The sponges range in size from 6mm × 76mm × 76mm. #### Intended Use: The device is intended to be used by trained physicians during neurosurgical procedures to protect neural tissues from drying, abrasion, or contamination and to absorb fluids. #### Indications for Use: The device is indicated for use by trained physicians during neurosurgical procedures to protect neural tissues from drying, abrasion, or contamination and to absorb fluids: #### Substantial Equivalence: The modified American Surgical Sponges (brand) Neurosurgical Sponges is equivalent to the previously cleared 510(k) (K962807, May 2, 1997) as these devices: - have the same indications for use and intended use, . - use the same principle of operation, . - . incorporate the same basic design, - incorporate equivalent materials, . - have the same shelf life, and . - . are packaged and sterilized using the same materials and processes. In summary, the modification to the American Surgical Sponges (brand) Neurosurgical Sponges described in this submission is substantially equivalent to the predicate device. American Surgical Company Special 510(k) {2}------------------------------------------------ #### Biocompatibility Testing: PTFE is widely used in medical devices. Biocompatibility testing conducted included Cytotoxicity, Sensitization and Irritation testing. Testing was completed in accordance with FDA's Blue Book Guidance G95-1 ("Use of International Standard ISO-10993, 'Biological' Evaluation of Medical Devices Part 1: Evaluation and Testing' "). The results of the studies demonstrate the lack of toxicity of the device and its biocompatibility for use as a neurosurgical sponge. All studies were conducted in compliance with U.S. Food and Drug Administration Good Laboratory Practice (GLP) regulations set forth in 21 CFR part 58. #### Performance Standards: No performance standards have been promulgated under Section 514 of the Food, Drug and Cosmetic Act for these devices. However, American Surgical Company conducted peel testing to quantify the amount of force necessary to pull apart the substrate and PTFE layers. {3}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol that resembles an abstract human figure or a caduceus, with flowing lines representing movement or connection. June 20, 2013 Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002 American Surgical Company, LLC c/o Mr. Michael Alouane LSSBB Director of Quality 82 Sanderson Ave., Suite 212 Lynn, MA 01902 Re: K112598 Trade/Device Name: American Surgical Company Neurosurgical Sponges Regulation Number: 21 CFR 882.4700 Regulation Name: Neurosurgical Paddie Regulatory Class: Class II Product Code: HBA Dated: June 5, 2013 Received: June 6, 2013 Dear Mr. Alouane: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {4}------------------------------------------------ #### Page 2 - Mr. Michael Alouane Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.goy/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely vours. # Victor Krauthamer -S Victor Krauthamer, Ph.D. Acting Director Division of Neurological and Physical Medicine Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ ## Indications for Use 510(k) Number (if known): K112598 Device Name: American Surgical Sponges (brand) Neurosurgical Sponges Indications For Use: The device is indicated for use by trained physicians during neurosurgical procedures to protect neural tissues from drying, abrasion, or contamination and to absorb fluids. Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Victor Krauthamer -S 2013.06.20 16:48:38 -04'00' (Division Sign Off) Division of Neurological and Physical Medicine Devices (DNPMD) 510(k) Number Page 1 of 1 --- **Source:** [https://fda.innolitics.com/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/HBA/K112598](https://fda.innolitics.com/submissions/NE/subpart-e%E2%80%94neurological-surgical-devices/HBA/K112598) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com